- Home
- INM vs FE Comparison
INM vs FE Comparison
Compare INM & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- FE
- Stock Information
- Founded
- INM 1981
- FE 1996
- Country
- INM Canada
- FE United States
- Employees
- INM N/A
- FE N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- FE Electric Utilities: Central
- Sector
- INM Health Care
- FE Utilities
- Exchange
- INM Nasdaq
- FE Nasdaq
- Market Cap
- INM 3.2M
- FE N/A
- IPO Year
- INM N/A
- FE N/A
- Fundamental
- Price
- INM $3.32
- FE $39.93
- Analyst Decision
- INM
- FE Buy
- Analyst Count
- INM 0
- FE 15
- Target Price
- INM N/A
- FE $46.15
- AVG Volume (30 Days)
- INM 9.5M
- FE 5.4M
- Earning Date
- INM 05-12-2025
- FE 07-29-2025
- Dividend Yield
- INM N/A
- FE 4.43%
- EPS Growth
- INM N/A
- FE 1.45
- EPS
- INM N/A
- FE 1.88
- Revenue
- INM $4,920,990.00
- FE $13,764,000,000.00
- Revenue This Year
- INM N/A
- FE $9.20
- Revenue Next Year
- INM N/A
- FE $3.82
- P/E Ratio
- INM N/A
- FE $21.36
- Revenue Growth
- INM N/A
- FE 8.03
- 52 Week Low
- INM $1.72
- FE $37.58
- 52 Week High
- INM $15.70
- FE $44.97
- Technical
- Relative Strength Index (RSI)
- INM 59.24
- FE 40.70
- Support Level
- INM $2.26
- FE $39.28
- Resistance Level
- INM $5.50
- FE $40.72
- Average True Range (ATR)
- INM 0.40
- FE 0.56
- MACD
- INM 0.11
- FE 0.01
- Stochastic Oscillator
- INM 37.04
- FE 40.12
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.